SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-019728
Filing Date
2018-01-25
Accepted
2018-01-25 16:14:02
Documents
6
Period of Report
2018-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d530511d8k.htm 8-K 20546
2 EX-1.1 d530511dex11.htm EX-1.1 184495
3 EX-5.1 d530511dex51.htm EX-5.1 11033
4 EX-99.1 d530511dex991.htm EX-99.1 6970
5 GRAPHIC g530511g0125083736404.jpg GRAPHIC 6339
6 GRAPHIC g530511g0125083908679.jpg GRAPHIC 3680
  Complete submission text file 0001193125-18-019728.txt   238405
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 18548421
SIC: 2836 Biological Products, (No Diagnostic Substances)